{"log_id": 1089901683594614325, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 0.000346, "average": 0.993369, "min": 0.890229}, "location": {"width": 822, "top": 164, "height": 48, "left": 237}, "words": "炎患者抗核抗体(ANA)(滴度≥1:40)的阳性比例(11%)大于安慰剂治疗组"}, {"probability": {"variance": 0.000672, "average": 0.993526, "min": 0.843632}, "location": {"width": 811, "top": 212, "height": 48, "left": 246}, "words": "(5%)。通过放射性免疫测定法(本品治疗组15%,安慰剂治疗组4%)和绿蝇"}, {"probability": {"variance": 2e-06, "average": 0.999008, "min": 0.994239}, "location": {"width": 823, "top": 260, "height": 49, "left": 234}, "words": "短膜豆分析法(本品治疗组3%,安慰剂治疗组0%)测得本品治疗患者抗双链"}, {"probability": {"variance": 3e-06, "average": 0.998738, "min": 0.992562}, "location": {"width": 823, "top": 309, "height": 49, "left": 233}, "words": "DNA抗体阳性的比例较高。本品治疗患者产生抗心磷脂抗体的增加比例与安慰"}, {"probability": {"variance": 1e-06, "average": 0.998966, "min": 0.996278}, "location": {"width": 597, "top": 358, "height": 44, "left": 230}, "words": "剂组相似。长期使用本品治疗对自身抗体产生的影响未知"}, {"probability": {"variance": 1e-05, "average": 0.998571, "min": 0.983254}, "location": {"width": 774, "top": 408, "height": 46, "left": 278}, "words": "罕见报告患者(包括类风湿因子阳性患者)产生其他自身抗体的同时出现狼"}, {"probability": {"variance": 4e-06, "average": 0.998668, "min": 0.991367}, "location": {"width": 824, "top": 454, "height": 49, "left": 227}, "words": "疮样综合征或皮疹,这些皮疹与亚急性皮肤红斑狼疮或盘状红斑狼疮的临床表现"}, {"probability": {"variance": 7e-06, "average": 0.998057, "min": 0.992718}, "location": {"width": 194, "top": 502, "height": 33, "left": 226}, "words": "和活组织检查相似"}, {"probability": {"variance": 1e-06, "average": 0.998891, "min": 0.997053}, "location": {"width": 97, "top": 552, "height": 28, "left": 226}, "words": "免疫原性"}, {"probability": {"variance": 6e-06, "average": 0.998563, "min": 0.989925}, "location": {"width": 544, "top": 596, "height": 45, "left": 272}, "words": "在接受本品治疗的成年类风湿关节炎、银屑病关节炎"}, {"probability": {"variance": 0.018718, "average": 0.942095, "min": 0.581367}, "location": {"width": 239, "top": 603, "height": 49, "left": 807}, "words": "直性脊柱炎和银屑"}, {"probability": {"variance": 0.009825, "average": 0.971524, "min": 0.466338}, "location": {"width": 814, "top": 643, "height": 51, "left": 221}, "words": "病患者的血清中,约6%的患者至少检测出一次抗TNF变体或品其他蛋白组分"}, {"probability": {"variance": 0.001462, "average": 0.988307, "min": 0.801563}, "location": {"width": 824, "top": 688, "height": 57, "left": 220}, "words": "的抗体,这些抗体均非中和抗体。接受本品治疗的幼年特发性关节炎患者的免疫"}, {"probability": {"variance": 7e-06, "average": 0.998851, "min": 0.988278}, "location": {"width": 458, "top": 740, "height": 41, "left": 218}, "words": "原性检测结果和成年类风湿关节炎患者相似"}, {"probability": {"variance": 0.007396, "average": 0.97108, "min": 0.548861}, "location": {"width": 777, "top": 785, "height": 55, "left": 265}, "words": "银屑病患者接受本品治疗120周,在4周48周/72周/96周检测时间点的抗"}, {"probability": {"variance": 0.010648, "average": 0.968309, "min": 0.370976}, "location": {"width": 865, "top": 836, "height": 49, "left": 216}, "words": "体阳性率为36%87%,这些抗体均非中和抗体。抗体阳性的患者比例随疗程增"}, {"probability": {"variance": 0.008298, "average": 0.965622, "min": 0.632021}, "location": {"width": 823, "top": 880, "height": 51, "left": 212}, "words": "加而升高,但该结果的临床意义尚不清楚。抗体的产生与临床疗效或术食"}, {"probability": {"variance": 0.007777, "average": 0.981963, "min": 0.468725}, "location": {"width": 828, "top": 927, "height": 57, "left": 211}, "words": "有明显关联性。目前尚不清楚接变本品治疗超过120周患者的免疫原性发生情"}, {"probability": {"variance": 0, "average": 0.999833, "min": 0.999833}, "location": {"width": 26, "top": 981, "height": 26, "left": 212}, "words": "况"}, {"probability": {"variance": 0.001786, "average": 0.987403, "min": 0.797306}, "location": {"width": 778, "top": 1023, "height": 55, "left": 259}, "words": "本数据反应的是采角 ELISA方法检测抗体阳性的患者百分比,这些数据很"}, {"probability": {"variance": 0.001252, "average": 0.98658, "min": 0.810065}, "location": {"width": 826, "top": 1068, "height": 58, "left": 210}, "words": "大程度上依赖于该分析方法的灵敏度和特异性。另外,除灵敏度和特异性外,分"}, {"probability": {"variance": 2.2e-05, "average": 0.997606, "min": 0.975609}, "location": {"width": 825, "top": 1119, "height": 51, "left": 207}, "words": "析过程中影响抗体阳性结果判断的其它因素还包括测定方法学、样品处理、取样"}, {"probability": {"variance": 5.4e-05, "average": 0.997356, "min": 0.957078}, "location": {"width": 826, "top": 1168, "height": 48, "left": 205}, "words": "时间、合并用药和所患疾病。因此,将本品抗体阳性发生率和其他药物抗体的发"}, {"probability": {"variance": 1e-06, "average": 0.998988, "min": 0.9968}, "location": {"width": 316, "top": 1217, "height": 36, "left": 203}, "words": "生率进行比较可能会产生误导"}, {"probability": {"variance": 2e-06, "average": 0.998947, "min": 0.99571}, "location": {"width": 340, "top": 1266, "height": 35, "left": 204}, "words": "全血细胞减少和再生障碍性贫血"}, {"probability": {"variance": 1e-06, "average": 0.999379, "min": 0.994837}, "location": {"width": 773, "top": 1312, "height": 47, "left": 255}, "words": "上市后曾报告全血细胞减少症和再生障碍性贫血的病例,有些造成了死亡"}, {"probability": {"variance": 4.4e-05, "average": 0.995903, "min": 0.976818}, "location": {"width": 214, "top": 1360, "height": 34, "left": 210}, "words": "(参见“注意事项”)"}, {"probability": {"variance": 0, "average": 0.999247, "min": 0.998434}, "location": {"width": 126, "top": 1409, "height": 29, "left": 199}, "words": "间质性肺病"}, {"probability": {"variance": 4.3e-05, "average": 0.9974, "min": 0.973887}, "location": {"width": 763, "top": 1456, "height": 45, "left": 250}, "words": "上市后曾报告间质性肺病的病例(包括肺炎和肺纤维化),有些造成了死亡"}, {"probability": {"variance": 0, "average": 0.999632, "min": 0.998876}, "location": {"width": 124, "top": 1505, "height": 29, "left": 197}, "words": "实验室评价"}], "language": 3}